"Yue Yining"-Chinese pharmaceutical enterprise growth product brand

Release time:


From October 27th to 30th, the 27th National Pharmaceutical Economic Information Conference was held in Taizhou. Jianfeng Pharmaceutical's key innovative product "Yue Yining" (Aceclofenac Sustained Release Tablets) was selected by the organizer as "Chinese Pharmaceutical Enterprise Growth Power Product Brand".
Southern Pharmaceutical Economic Research Institute is an authoritative organization for the release of global pharmaceutical economic information, and plays an important role in China's pharmaceutical industry. The National Pharmaceutical Economic Information Conference is held once a year and has been held for 27 times so far. It has become a national annual event for the pharmaceutical profession. It is also the "vane" of the development of China's pharmaceutical industry and is known as the "Oscar" of the pharmaceutical industry ". In the "growth product brand" selected this time, the embodiment of innovation is a more prominent feature. Experts pointed out that as a high-tech industry in the pharmaceutical field, the growth of product brands is prominently reflected in the innovation and scientific value of the products themselves.
The "Yue Yining" produced by Jianfeng Pharmaceutical is a national invention patented product, which is mainly used to treat the symptoms of pain and inflammation caused by osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and can promote the regeneration and repair of articular cartilage. It can also be used to treat chronic polyarthritis, postoperative pain, post-traumatic pain, neck and shoulder pain, low back and leg pain, headache, migraine, sprain, toothache, dysmenorrhea, etc. The unique sustained-release new dosage form makes It has certain advantages in similar products, and its market sales are growing rapidly, which has been affirmed by industry experts.